ALPHA-1 antitrypsin genotype, sex, and lung cancer: Clinical and molecular characterisation
Open Access
- 17 September 2026
- journal article
- research article
- Published by Taylor & Francis in Pulmonology
- Vol. 32 (1)
Abstract
Alpha-1 antitrypsin deficiency (AATD) is a codominant genetic condition characterised by reduced serum alpha-1 antitrypsin (AAT) levels and an increased risk of lung and liver disease.1 AAT is a ne...Keywords
Funding Information
- Instituto de Salud Carlos III (PI00350/19)
- FEDER
This publication has 30 references indexed in Scilit:
- Global variations in lung cancer incidence by histological subtype in 2020: a population-based studyThe Lancet Oncology, 2023
- Lung cancer molecular mutations and abnormal glycosylation as biomarkers for early diagnosisCancer Treatment and Research Communications, 2021
- Alpha-1 antitrypsin deficiency and risk of lung cancer: A systematic reviewTranslational Oncology, 2021
- The IASLC Lung Cancer Staging Project: External Validation of the Revision of the TNM Stage Groupings in the Eighth Edition of the TNM Classification of Lung CancerJournal of Thoracic Oncology, 2017
- COPD, emphysema and the onset of lung cancer. A systematic reviewCancer Letters, 2016
- Lung cancer in never smokers – A reviewEuropean Journal of Cancer, 2012
- Guidelines for the Diagnosis and Management of α1-Antitrypsin DeficiencyArchivos de Bronconeumología, 2006
- Expression of Estrogen Receptor-α, Estrogen Receptor-β and Placental Endothelial and Inducible NO Synthase in Intrauterine Growth-Restricted and Normal PlacentasArchives of Medical Research, 2006
- α1-antitrypsin deficiencyThe Lancet, 2005
- Activation of progelatinase A (MMP‐2) by neutrophil elastase, cathepsin G, and proteinase‐3: A role for inflammatory cells in tumor invasion and angiogenesisJournal of Cellular Physiology, 2001